List today: Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 29th: GDS Holdings Limited GDS: This data center operator from China has a Zacks Rank #1 ...

The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

BioNTech (BNTX) is a stock many investors are watching right now. BNTX is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. We should also highlight that BNTX has a P/B ratio of 1.21.

Bristol Myers Squibb BMY announced a strategic collaboration agreement with BioNTech BNTX for the global co-development and ...

BNTX's current P/B looks attractive when compared to its industry's average P/B of 3.18. Over the past year, BNTX's P/B has been as high as 16.35 and as low as 1.70, with a median of 3.01.

Therefore, BNTX stock's valuation seems in line with its peers now. As a result of its fat coffers from the COVID-19 vaccine, BNTX is accelerating through its pipelines.